Search Legislation

Miscellaneous Food Additives (Amendment) Regulations (Northern Ireland) 1999

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)

More Resources

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Amendment of the principal Regulations

13.  In Schedule 8 (miscellaneous additives permitted in foods for infants and young children)—

(a)there shall be substituted for the first introductory note the following introductory notes—

1.  Formulae and weaning foods for infants and young children may contain E 414 (acacia gum, gum arabic) and E 551 (silicon dioxide) resulting from the addition of nutrient preparations containing not more than 150 g/kg of E 414 and 10 g/kg of E 551, as well as E 421 (mannitol) when used as a carrier for vitamin B12 (not less than 1 part vitamin B12 to 1000 parts mannitol). The carry over of E 414 in the product ready for consumption shall not be more than 10 mg/kg.

1A.  Formulae and weaning foods for infants and young children may contain E 301 (sodium L-ascorbate), used at quantum satis level in coatings of nutrient preparations containing polyunsaturated fatty acids. The carry over of E 301 in the product ready for consumption shall not be more than 75 mg/l.;

(b)in Part I (miscellaneous additives permitted in infant formulae for infants in good health)—

(i)there shall be substituted for note (b) the following note—

(b)if more than one of the substances E 322, E 471, E 472c and E 473 is added to a food, the maximum level established for that food for each of those substances is lowered by that relative part as is present of the other substances together in that food.;

(ii)in the table where there shall be inserted at the end the following entries—

E 304L-ascorbyl palmitate10 mg/1
E 331Sodium citrates2 g/1
E 332Potassium citratesIndividually or in combination and in conformity with the limits set in Annex 1 to Directive 91/321/ EEC(1)
E 339Sodium phosphates1 g/1 expressed as P2O5
E 340Potassium phosphatesIndividually or in combination and in conformity with the limits set in Annex 1 to Directive 91/321/EEC
E 412Guar gum1 g/1, where the liquid product contains partially hydrolysed proteins and is in conformity with the conditions set in Annex IV to Directive 91/321 EEC, as amended by Directive 96/4/EC(2)
E472cCitric acid esters of mono-and diglycerides of fatty acids7.5 g/1 sold as powder
g/1 sold as liquid where the products contain partially hydrolysed proteins, peptides or amino acids and are in conformity with the conditions set in Annex IV to Directive 91/321/EEC, as amended by Directive 96/4/EC
E 473Sucrose esters of fatty acids120 mg/1 in products containing hydrolysed proteins, peptides or amino acids;

(c)in Part II (miscellaneous additives permitted in follow-on formulae for infants in good health)—

(i)there shall be substituted for note (b) the following note—

(b)if more than one of the substances E 322, E 471, E 472c and E 473 is added to a food, the maximum level established for that food for each of those substances is lowered by that relative part as is present of the other substances together in that food.;

(ii)in note (c) there shall be substituted for the words “lowered with” the words “lowered by”;

(iii)in the table there shall be inserted at the end the following entries—

E 304L-ascorbyl palmitate10 mg/1
E 331Sodium citrates2 g/1
E 332Potassium citratesIndividually or in combination and in conformity with the limits set in Annex 1 to Directive 91/321/EEC
E 339Sodium phosphates1 g/1 expressed as P2O5
E 340Potassium phosphatesIndividually or in combination and in conformity with the limits set in Annex 1 to Directive 91/321/EEC
E 472cCitric acid testers of mono-and diglycerides of fatty acids

7.5 g/1 sold as powder.

9 g/1 sold as liquid where the products contain partially hydrolised proteins, peptides or amino acids and are in conformity with the conditions set in Annex IV to Directive 91/321/EEC, as amended by Directive 96/4/EC

E 473Sucrose esters of fatty acids120 mg/1 in products containing hydrolysed proteins, peptides or amino acids;

(d)in Part III (miscellaneous additives permitted in weaning foods for infants and young children in good health) in the table there shall be inserted at the end the following entries—

(*)

The note in Part IV does not apply.;

E 333Calcium citrates(*)Low-sugar fruit based productsquantum satis
E 341Tricalcium phosphate(*)Fruit based desserts1 g/kg as P2O5
E 1451Acetylated oxidised starchWeaning foods50 g/kg

(e)in Part IV (miscellaneous additives permitted in foods for infants and young children for special medical purposes) there shall be inserted at the end the following table—

EC No.NameMax. levelSpecial Conditions
E 401Sodium alginate1 g/1From 4 months onwards in special food products with adapted composition, required for metabolic disorders and for general tube feeding
E 405Propane 1, 2-diolalginate200 mg/1From 12 months onwards in specialised diets intended for young children who have cows' milk intolerance or inborn errors of metabolism
E 410Locust bean gum10 g/1From birth onwards in products for reduction of gastro-oesophageal reflux
E 412Guar gum10 g/1From birth onwards in products in liquid formulae containing hydrolysed proteins, peptides or amino acids in conformity with the conditions set in Annex IV to Directive 91/321/EEC, as amended by Directive 96/4/EC
E 415Xanthan gum1.2 g/1From birth onwards for use in products based on amino acids or peptides for use with patients who have problems with impairment of the gastro-intestinal tract, protein mal-absorption or inborn errors of metabolism
E 440Pectins10 g/1From birth onwards in products used in case of gastro-intestinal disorders
E 466Sodium carboxy methyl cellulose10g/1 or kgFrom birth onwards in products for the dietary management of metabolic disorders
E 471Mono-and diglycerides of fatty acids5 g/1From birth onwards in specialised diets, particularly those devoid of proteins
E 1450Starch sodium octenyl succinate20 g/1In infant formulae and follow-on formulae.
(1)

O.J. No. L175, 4.7.91, p. 35

(2)

O.J. No. L49, 28.2.96, p. 12

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources